Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

FUSN
Fusion Pharmaceuticals Inc. Common Shares
stock NASDAQ

Inactive
Jun 3, 2024
21.55USD+0.139%(+0.03)6,089,181
Pre-market
0.00USD-100.000%(-21.52)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 21, 2022
08:31AM EST  Fusion Pharmaceuticals to Present at the B. Riley Securities 2022 Virtual   PR Newswire
Jan 18, 2022
04:30PM EST  Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule   PR Newswire
Jan 11, 2022
08:26AM EST  Fusion Pharmaceuticals Announces Research Collaboration With 48Hour Discovery To Develop Peptide-Based Radiopharmaceuticals; Fusion Has Global Rights To Develop And Commercialize Any Peptides Discovered Under The Collaboration   Benzinga
08:20AM EST  Fusion Pharma Enters Research Collaboration With 48Hour Discovery To Develop Peptide-Based Radiopharmaceuticals   RTTNews
08:19AM EST  Fusion Pharma Unveils Research Collaboration With Pepscan To Develop Peptide-Based Radiopharmaceuticals   RTTNews
08:18AM EST  Fusion Pharmaceuticals Announces Research Collaboration With Pepscan tT Develop Peptide-Based Radiopharmaceuticals; Fusion Will Have Global Rights To Develop And Commercialize Any Peptides Discovered Under Collaboration   Benzinga
08:16AM EST  Fusion Pharmaceuticals Announces Research Collaboration with Pepscan to Develop   PR Newswire
08:15AM EST  Fusion Pharmaceuticals Announces Research Collaboration with 48Hour Discovery   PR Newswire
Jan 10, 2022
04:33PM EST  Fusion Pharmaceuticals Announces Nomination Of First Targeted Alpha Therapy Candidate In Collaboration With AstraZeneca To Advance Into IND-Enabling Studies For Phase 1 Development   Benzinga
04:30PM EST  Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development   PR Newswire
Nov 11, 2021
04:15PM EST  Fusion Pharmaceuticals To Present At The 2021 Jefferies London Healthcare   PR Newswire
Nov 9, 2021
11:35AM EST  Fusion Pharmaceuticals Q3 EPS $(0.45) Down From $(0.24) YoY   Benzinga
07:33AM EST  Fusion Pharma Q3 Net Loss $19.4 Mln Or $0.45/Shr Vs Loss Of $10.0 Mln Or $0.24/Shr Last Year   RTTNews
07:31AM EST  Fusion Pharmaceuticals Announces Third Quarter 2021 Financial Results and   PR Newswire
Nov 3, 2021
04:30PM EDT  Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule   PR Newswire
Nov 2, 2021
05:43PM EDT  Fusion Pharmaceuticals Appoints Christopher Leamon, Ph.D., As Chief Scientific Officer   Benzinga
04:16PM EDT  Fusion Pharmaceuticals Appoints Industry Veteran Christopher Leamon, Ph.D., as   PR Newswire
Oct 21, 2021
12:10PM EDT  Fusion Pharmaceuticals Announces Presentation Of Preclinical Data Supporting Its FPI-1966 And FPI-2059 Targeted Alpha Therapies   Benzinga
Oct 20, 2021
04:06PM EDT  Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting   PR Newswire
Sep 28, 2021
04:10PM EDT  Fusion Pharmaceuticals Appoints Mohit Rawat As President And Chief Business Officer   Benzinga
04:05PM EDT  Fusion Pharmaceuticals Appoints Mohit Rawat as President and Chief Business   PR Newswire
Sep 23, 2021
04:20PM EDT  Fusion Pharma To Present At Cantor Global Healthcare Conference Wednesday, Sept. 29 At 2:40 p.m. EDT   Benzinga
04:10PM EDT  Fusion Pharmaceuticals To Present At The 2021 Cantor Fitzgerald Virtual Global   PR Newswire
Sep 21, 2021
08:35AM EDT  Fusion Pharmaceuticals Appoints Eric S. Hoffman, Ph.D. as Senior Vice   PR Newswire
Sep 6, 2021
10:27AM EDT  5 Value Stocks In The Healthcare Sector   Benzinga
Sep 2, 2021
04:10PM EDT  Fusion Pharmaceuticals to Participate in Upcoming Investor Conferences   PR Newswire
Aug 31, 2021
04:31PM EDT  Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule   PR Newswire
Aug 26, 2021
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021   Benzinga
06:07AM EDT  B. Riley Securities Initiates Coverage On Fusion Pharmaceuticals with Buy Rating, Announces Price Target of $17   Benzinga
Aug 18, 2021
07:39AM EDT  Morgan Stanley Maintains Overweight on Fusion Pharmaceuticals, Lowers Price Target to $19   Benzinga
Aug 12, 2021
04:50PM EDT  Fusion Pharma Reports Expansion Of R&D Collab With TRIUMF For Actinium Supply Production; Fusion Will Continue Its Investment Of Up To C$25M In TRIUMF   Benzinga
04:06PM EDT  Fusion Pharmaceuticals and TRIUMF Announce Expanded R&D Collaboration for   PR Newswire
Aug 10, 2021
07:37AM EDT  Fusion Pharma Q2 Net Loss $26.9 Mln Or $0.63/Shr Vs Loss Of $44.7 Mln Or $18.91/Shr Last Year   RTTNews
07:34AM EDT  Fusion Pharmaceuticals Q2 EPS $(0.63) Up From $(2.99) YoY   Benzinga
07:31AM EDT  Fusion Pharmaceuticals Announces Second Quarter 2021 Financial Results and   PR Newswire
Aug 5, 2021
04:06PM EDT  Fusion Pharmaceuticals to Participate in the 2021 Wedbush PacGrow Healthcare   PR Newswire
Jul 29, 2021
08:18AM EDT  The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs   Benzinga
07:10AM EDT  Fusion Pharma Stock Is Trading Higher As FDA Clears Early-Stage Study For Radiopharmaceutical In Neck, Bladder Cancers   Benzinga
Jul 28, 2021
04:17PM EDT  Fusion Pharma Reports FDA Clearance Of Investigational New Drug Application For FPI-1966 For Treatment Of Head, Neck, Bladder Cancers Expressing Fibroblast Growth Factor 3   Benzinga
04:16PM EDT  Investigational Radiopharmaceutical for the Treatment of Head and Neck and Bladder Cancers Expressing FGFR3   PR Newswire
Jul 7, 2021
08:02AM EDT  Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule   PR Newswire
Jul 2, 2021
04:29PM EDT  Fusion Pharmaceuticals Files For Mixed Securities Shelf Offering Of Up To $400M   Benzinga
Jun 16, 2021
05:02AM EDT  44 Biggest Movers From Yesterday   Benzinga
Jun 15, 2021
12:54PM EDT  Shares of Fusion Pharmaceuticals Inc. (FUSN) are gaining nearly 15% on Tuesday morning after the clinical-stage oncology company reported positive safety and dosimetry results from its early stage study of FPI-1434.   RTTNews
Jun 14, 2021
04:33PM EDT  Fusion Pharma Reports Preliminary Results From Single-Dose Portion Of Phase 1 Study Of FPI-1434   RTTNews
04:11PM EDT  Pharmaceuticals Announces Preliminary Safety And Dosimetry Results From Single-Dose Portion Of Phase 1 Study Of FPI-1434 ; Says Candidate 'demonstrated a favorable safety profile with no drug-related serious adverse events or dose-limiting toxicity'   Benzinga
04:10PM EDT  Fusion Pharmaceuticals Announces Preliminary Safety and Dosimetry Results from   PR Newswire
Jun 7, 2021
04:13PM EDT  Fusion Pharmaceuticals Appoints Isabelle Dussault As SVP, Research   RTTNews
04:10PM EDT  Fusion Pharmaceuticals Appoints Isabelle Dussault, Ph.D. as Senior Vice   PR Newswire
Jun 2, 2021
08:59AM EDT  Fusion Pharmaceuticals Enters 15-year Lease Agreement With Hamilton, Ontario-based McMaster University   RTTNews
08:38AM EDT  Fusion Pharma Signs Deal To Build Radiopharmaceutical Manufacturing Facility   RTTNews
08:31AM EDT  Fusion Pharmaceuticals Enters Into Lease Agreement To Build Radiopharmaceutical Manufacturing Facility; Financial Terms Not Disclosed   Benzinga
08:31AM EDT  Fusion Pharmaceuticals Enters into Agreement to Build Radiopharmaceutical   PR Newswire
May 19, 2021
07:30AM EDT  The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics   Benzinga
May 18, 2021
10:03AM EDT  Morgan Stanley Maintains Overweight on Fusion Pharmaceuticals, Lowers Price Target to $20   Benzinga
07:44AM EDT  The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO   Benzinga
May 11, 2021
07:54AM EDT  Fusion Pharmaceuticals Q1 EPS $(0.42) Up From $(6.01) YoY   Benzinga
07:36AM EDT  Fusion Pharmaceuticals Q1 Net Loss $17.5 Mln Or $0.42 Per Share   RTTNews
07:31AM EDT  Fusion Pharmaceuticals Announces First Quarter 2021 Financial Results and   PR Newswire
May 6, 2021
10:46AM EDT  Fusion Pharma Shares Move Higher After Trial Collab With Merck For IGF-1R-Expressing Cancer Study   Benzinga
09:50AM EDT  Fusion Pharmaceuticals Inc. (FUSN) said that it has reached a clinical trial collaboration with a subsidiary of Merck & Co Inc. (MRK) to evaluate Fusion's lead candidate, [225Ac]-FPI-1434 (FPI-1434), in combination with Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in patients with solid tumors expressing insulin-like growth factor 1 receptor (IGF-1R).   RTTNews
09:24AM EDT  Fusion Collaborates With Merck To Evaluate Fusion' TAT In Combination With Merck' KEYTRUDA In Patients With Solid Tumors   RTTNews
08:51AM EDT  Fusion Pharmaceuticals Announces Clinical Collaboration With Merck To Evaluate Fusion's Targeted Alpha Therapy In Combination With Merck's KEYTRUDA In Patients With Solid Tumors Expressing IGF-1R   Benzinga
08:21AM EDT  Fusion's Targeted Alpha Therapy (TAT) in Combination with Merck's KEYTRUDA(r) (pembrolizumab) in Patients With Solid Tumors Expressing IGF-1R   PR Newswire
Apr 21, 2021
07:31AM EDT  The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue   Benzinga
Apr 20, 2021
08:07AM EDT  The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex   Benzinga
Apr 19, 2021
10:18AM EDT  Stocks That Hit 52-Week Lows On Monday   Benzinga
Apr 14, 2021
08:45AM EDT  Fusion Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor   PR Newswire
Apr 13, 2021
08:22AM EDT  Fusion Acquisition Corp. SPAC Merger Partner MoneyLion Reports Q4 Adj. Revenue $25.5M, Up 119% YoY, total Customers 1.4M, Up 60%   Benzinga
08:16AM EDT  The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug   Benzinga
Apr 10, 2021
08:35AM EDT  Fusion Pharmaceuticals Announces Preclinical Combination Data Demonstrating   PR Newswire
Apr 6, 2021
09:07AM EDT  Novel Cancer Therapy Phase 3 Trial Expects To Be Completed Shortly   Benzinga
08:53AM EDT  Morgan Stanley Maintains Overweight on Fusion Pharmaceuticals, Lowers Price Target to $21   Benzinga
Apr 1, 2021
04:15PM EDT  Fusion Pharmaceuticals Announces Closing of Acquisition of IPN-1087, a Small   PR Newswire
08:02AM EDT  Fusion Pharmaceuticals Appoints Donald Bergstrom To Board   RTTNews
08:02AM EDT  Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of   PR Newswire
Mar 31, 2021
07:41AM EDT  The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO   Benzinga
Mar 30, 2021
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
Mar 26, 2021
07:28AM EDT  The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs   Benzinga
Mar 25, 2021
07:39AM EDT  Fusion Pharma Q4 Net Loss $13.4 Mln Or $0.32/Shr Vs Loss Of $8.2 Mln Or $4.25/Shr Last Year   RTTNews
07:33AM EDT  Fusion Pharmaceuticals Q4 EPS $(0.32) Up From $(4.25) YoY   Benzinga
07:31AM EDT  Fusion Pharmaceuticals Announces Fourth Quarter 2020 Financial Results and   PR Newswire
Mar 2, 2021
07:34AM EST  Fusion Pharmaceuticals Acquires IP And Assets Related To IPN-1087, Small Molecule Targeting NTSR1, From Ipsen; Financial Details Not Disclosed   Benzinga
07:31AM EST  Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small   PR Newswire
Feb 23, 2021
04:30PM EST  Fusion Pharmaceuticals To Present At The Cowen 41st Annual Health Care   PR Newswire
Feb 11, 2021
08:01AM EST  Fusion Pharmaceuticals Appoints Philina Lee, Ph.D., to Board of Directors   PR Newswire
Jan 29, 2021
07:45AM EST  The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO   Benzinga
Jan 28, 2021
08:03AM EST  The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO   Benzinga
Jan 13, 2021
07:25AM EST  The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations   Benzinga
Jan 8, 2021
07:25AM EST  The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs   Benzinga
Jan 5, 2021
09:30AM EST  2020 Canadian IPO mixed results - number (77) down, amount ($5.55B) up driven   PR Newswire
Dec 22, 2020
10:46PM EST  The lockup period of Fusion Pharmaceuticals Inc. (FUSN) ends on December 23..   RTTNews
Dec 16, 2020
09:05AM EST  TRIUMF Enters Collaboration With Fusion Pharmaceuticals To Boost Production Of Actinium-225   Benzinga
09:00AM EST  TRIUMF Enters Collaboration with Fusion Pharmaceuticals to Boost   GlobeNewswire Inc
Dec 10, 2020
08:36AM EST  Fusion Pharmaceuticals Begins Multi-Dose Portion Of Phase 1 Trial Of FPI-1434 In Patients With Advanced Solid Tumors   RTTNews
08:22AM EST  Fusion Pharma Says Begins Multi-Dose Portion Of Phase 1 Trial Of FPI-1434 In Patients With Advanced Solid Tumors   RTTNews
08:13AM EST  Fusion Pharmaceuticals Initiates Multi-Dose Portion Of Phase 1 Trial Of FPI-1434 In Patients With Advanced Solid Tumors   Benzinga
08:10AM EST  Fusion Pharmaceuticals Initiates Multi-Dose Portion of Phase 1 Trial of   PR Newswire
Nov 12, 2020
04:10PM EST  Fusion Pharmaceuticals to Present at the Jefferies Virtual London Healthcare   PR Newswire
Nov 10, 2020
07:13AM EST  Fusion Pharma Q3 Net Loss $10.0 Mln Or $0.24/Shr Vs Loss Of $0.6 Mln Or $0.31/Shr Last Year   RTTNews
07:01AM EST  Fusion Pharmaceuticals Announces Third Quarter 2020 Financial Results and   PR Newswire
Nov 2, 2020
04:22PM EST  Fusion Pharma Names Barbara Duncan Chair   Benzinga
04:13PM EST  Fusion Pharmaceuticals Appoints Barbara Duncan As Chairperson Of Board   RTTNews
04:10PM EST  Fusion Pharmaceuticals Appoints Barbara Duncan as Chairperson of the Board of   PR Newswire
07:12AM EST  Fusion Pharmaceuticals Announces Collaboration with AstraZeneca to Develop and Commercialize Next-Generation Radiopharmaceuticals and Combination Therapies   Benzinga
07:05AM EST  Fusion Pharma, AstraZeneca Collaborate To Develop Next-Generation Radiopharmaceuticals And Combination Therapies   RTTNews
07:01AM EST  Fusion Pharmaceuticals Announces Collaboration with AstraZeneca to Develop and   PR Newswire
Sep 29, 2020
04:17PM EDT  Fusion Pharmaceuticals Appoints Maria Stahl As Chief Legal Officer   RTTNews
Sep 10, 2020
09:01AM EDT  Fusion Pharmaceuticals to Present at the Morgan Stanley Virtual 18th Annual   PR Newswire
Aug 11, 2020
07:34AM EDT  Fusion Pharma Q2 Net Loss $44.7 Mln Or $18.91/Shr Vs Loss Of $3.5 Mln Or $1.79/Shr Last Year   RTTNews
07:25AM EDT  Fusion Pharmaceuticals Announces Second Quarter 2020 Financial Results and   PR Newswire
Aug 5, 2020
08:02AM EDT  Fusion Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare   PR Newswire
Jul 21, 2020
09:37AM EDT  Benzinga's Top Upgrades, Downgrades For July 21, 2020   Benzinga
09:28AM EDT  Morgan Stanley Initiates Coverage On Fusion Pharmaceuticals with Overweight Rating, Announces Price Target of $23   Benzinga
07:37AM EDT  Cowen & Co. Initiates Coverage On Fusion Pharmaceuticals with Outperform Rating   Benzinga
07:36AM EDT  Wedbush Initiates Coverage On Fusion Pharmaceuticals with Outperform Rating, Announces Price Target of $25   Benzinga
05:50AM EDT  Jefferies Initiates Coverage On Fusion Pharmaceuticals with Buy Rating, Announces Price Target of $25   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC